Medical devices in dermatology: topical semi‐solid formulations for the treatment of skin diseases
- 18 August 2011
- journal article
- review article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 10 (2) , 103-109
Abstract
In recent years, topically applied semi‐solid formulations certified as medicals devices and not as topical drugs are increasingly used for the treatment of skin diseases. Medical devices primarily unfold their therapeutic effect by physical means, not by pharmacological, immunological or metabolic means. Intensified placing of medical devices on the dermatological market may at least partly be explained by a less complex marketing authorization process compared to topical drugs. If the requirements are fulfilled to certify a product as a medical device the opportunity will be offered to quickly introduce innovations onto the market and propagate them. A variety of evidence‐based medical devices for several dermatological indications are presented here.Keywords
This publication has 27 references indexed in Scilit:
- Recent insights into atopic dermatitis and implications for management of infectious complicationsJournal of Allergy and Clinical Immunology, 2010
- A new two-phase dimeticone pediculicide shows high efficacy in a comparative bioassayBMC Dermatology, 2009
- Epidermal Barrier Dysfunction in Atopic DermatitisJournal of Investigative Dermatology, 2009
- A double‐blind, randomized, vehicle‐controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIRTM) in the management of atopic dermatitis in paediatric patientsPediatric Allergy and Immunology, 2008
- A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trialBMC Infectious Diseases, 2008
- MAS063DP is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children: A Multicenter, Randomized, Vehicle-Controlled StudyThe Journal of Pediatrics, 2008
- Sunscreens in organ transplant patientsNephrology Dialysis Transplantation, 2008
- Patient‐reported outcomes from a multicenter, randomized, vehicle‐controlled clinical study of MAS063DP (Atopiclair™) in the management of mild‐to‐moderate atopic dermatitis in adultsJournal of Dermatological Treatment, 2008
- 1.1 Introduction2008
- High in vitro efficacy of Nyda® L, a pediculicide containing dimeticoneJournal of the European Academy of Dermatology and Venereology, 2007